GlassScriptPhysician profile
Ruth D Johnson
NPI 1316272453
$848.34
in general payments reported to CMS, 2019-2025
9 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $251 · 2022: $355 · 2023: $130 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $242.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $164.06 | 2022-2023 | Reblozyl |
| Lilly USA, LLC | $161.19 | 2021-2022 | |
| Janssen Biotech, INC. | $112.55 | 2025 | Talvey |
| Gilead Sciences, INC. | $99.98 | 2022 | |
| Epizyme, INC. | $69.42 | 2021 | |
| Kite Pharma, INC. | $67.16 | 2021 | |
| Janssen Scientific Affairs, LLC | $62.58 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $60.14 | 2021 | |
| Novartis Pharmaceuticals Corporation | $51.26 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.